RTA compliance certificate for Q2 FY27 filed with exchanges
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 1.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Gufic Biosciences has submitted the quarterly certificate from its Registrar and Share Transfer Agent, MUFG Intime India, under SEBI Regulation 74(5) for the quarter ended September 30, 2026. The certificate confirms that securities received for dematerialisation during the quarter were processed and accepted or rejected, that the underlying securities remain listed on the stock exchanges, and that the depositories have been recorded as registered owners within the required timelines. The filing was made to both BSE and NSE.
Routine regulatory compliance submission. No material impact on operations, financials, or share price.